New Delhi [India], August 1: In a significant step toward strengthening healthcare accessibility, Healing Pharma India Private Limited (HPIPL), one of India's fast-growing pharmaceutical companies, has donated an ambulance to Bhakti Siddhant Hospital, Pune. This life-saving gesture comes und
Indian pharmaceutical manufacturers are preparing a two-pronged strategy to offset the impact of the soon-to-be-effective 25 per cent US tariff on Indian goods, which includes drug exports, with industry experts anticipating that the move could significantly raise medicine costs in the Ameri
Speaking about the challenges facing India's export-dependent sectors, Dawra highlighted concerns for labour-intensive industries, including electronics, jewellery, pharmaceuticals, textiles, and leather goods, that could be significantly impacted by changing trade dynamics.
The US's move has raised concerns about India's export outlook, as the US is one of the country's largest export destinations. The fresh round of tariffs has sparked fears that Indian products will become more expensive in the US market, making them less competitive compared to goods from ot
In a significant crackdown on illegal pharmaceutical drug trafficking, the Amritsar Police Commissionerate has unearthed a sophisticated Tramadol supply chain originating from Uttarakhand's Haridwar, following a minor initial recovery of just 35 tablets in Amritsar.
Mumbai (Maharashtra) [India], July 31: Jyoti Global Plast Limited, a leading plastic and FRP moulding company with its recent foray into defence and aerospace, is planning to raise Rs. 35.44 crore through SME Initial Public Offering (IPO). The company has received approval to launch its publ
Mumbai (Maharashtra) [India], July 31: Fredun Pharmaceuticals Limited (BSE - FREDUN | 539730), is one of the Leading pharmaceutical formulation manufacturing companies in India. Diversified into Generics, Cosmeceuticals, Nutraceuticals, Mobility and Animal Healthcare Products, has reported i
The Indian pharmaceutical industry has hit back strongly at the recent tariff announcement by U.S. President Donald Trump, calling it a move that could hurt the American healthcare system more than India's economy.
"It is a sad day for Indian exports because India is doing exports worth over 100 billion dollars and our surplus is over $40 billion. It will slow down some of our exports and there will be a ripple effect on our manufacturing, particularly in carpet, pharmaceuticals and handicrafts sect
While speaking to ANI, Economist Suriya Narayanan stated, "This is a setback to India because India was exporting pharmaceuticals, copper, metals and more with zero tariffs. Now India has to pay for products exported to the US. This will impact the Indian exporters... This will impact the In
While some trade and industry leaders warned of short-term disruptions, others expressed confidence that India's strong manufacturing base, especially in sectors such as pharmaceuticals and medical equipment, would help it withstand the impact and forge new trade partnerships.